Episode 263 hosts Dr David Eccleston (Cosmetic Physician based in Birmingham, UK)

David joins us for chapter 8 of our mini-series 'The Tox Talks'. In these episodes we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.

In chapter 8 we learn about one of the newest toxin brands called Nuceiva (Prabotulinum Toxin Type A). Manufactured by Evolus and also known as Jeuveau in the USA, Nuceiva will formally launch in Australia this week.

00:00 Introduction 03:25 Dr David Eccleston 04:04 Early Botox Days 07:38 Couture Toxins Approach 09:34 Training and UK Regulation 14:32 KOLs and Conflicts 18:00 Longer Lasting Toxin Debate 20:20 Toxin Science and Spread 27:18 Everly Company Backstory 32:37 Freeze vs Vacuum Drying 38:51 Packaging and Reconstitution 41:17 Preserved Saline Myths 45:07 Comparing Toxins and Consent 48:11 Consent and Disclosure 50:08 Placebo and Brand Bias 50:42 Switching to New Toxin 53:58 Technique and Dosing Nuance 58:33 Dilution and Equipment 01:02:10 Marketing and Regulation 01:03:24 Commercial Pricing Reality 01:10:29 Clinical Trials and Millennials 01:15:58 Resistance and Case Studies 01:21:26 Aftercare and Pregnancy 01:25:44 Future of Toxins 01:33:12 Conference and Wrap Up

ALL IA LINKS & CONTACT INFORMATION